These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14601307)

  • 1. [PPAR-gamma expression in the kidney of actively proliferating glomerulonephritis].
    Xiong Z; Huang H; Li J; Wang H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 35(5):499-502. PubMed ID: 14601307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of urinary macrophages expressing the CD16 (Fc gamma RIII) molecule: a novel marker of acute inflammatory glomerular injury.
    Hotta O; Yusa N; Ooyama M; Unno K; Furuta T; Taguma Y
    Kidney Int; 1999 May; 55(5):1927-34. PubMed ID: 10231456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney.
    Abe K; Miyazaki M; Koji T; Furusu A; Ozono Y; Harada T; Sakai H; Nakane PK; Kohno S
    Kidney Int; 1998 Jul; 54(1):120-30. PubMed ID: 9648070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of DNA topoisomerases in chronic proliferative kidney disease.
    Ivanova LV; Rudolph P; Kellner U; Jürgensen A; Tareeva IE; Alm P; Proppe D
    Kidney Int; 2000 Oct; 58(4):1603-12. PubMed ID: 11012894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
    Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
    BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.
    Xiao J; Leung JC; Chan LY; Guo H; Lai KN
    Nephrol Dial Transplant; 2009 Jul; 24(7):2067-77. PubMed ID: 19155534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis.
    Jinde K; Nikolic-Paterson DJ; Huang XR; Sakai H; Kurokawa K; Atkins RC; Lan HY
    Am J Kidney Dis; 2001 Oct; 38(4):761-9. PubMed ID: 11576879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraglomerular synthesis of complement C3 and its activation products in IgA nephropathy.
    Abe K; Miyazaki M; Koji T; Furusu A; Shioshita K; Tsukasaki S; Ozono Y; Harada T; Sakai H; Kohno S
    Nephron; 2001 Mar; 87(3):231-9. PubMed ID: 11287758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis and proliferating cell nuclear antigen in lupus nephritis (class IV) and membranoproliferative glomerulonephritis.
    Kirim S; Tamer T; Saime P; Gönlüşen G
    Ren Fail; 2005; 27(1):107-13. PubMed ID: 15717643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological spectrums and renal prognosis of severe lupus patients with rapidly progressive glomerulonephritis.
    Chen S; Chen H; Liu Z; Zhang H; Hu W; Tang Z; Liu Z
    Rheumatol Int; 2015 Apr; 35(4):709-17. PubMed ID: 25281226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrospective study of primary IgA nephropathy with crescent formation and/or rapidly progressive glomerulonephritis in children].
    Wang D; Wang F; Ding J; Xiao H; Zhong X; Liu X
    Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):670-5. PubMed ID: 26757967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive effect of PPAR-γ agonist and ARB in treatment of experimental IgA nephropathy.
    Lai KN; Chan LY; Guo H; Tang SC; Leung JC
    Pediatr Nephrol; 2011 Feb; 26(2):257-66. PubMed ID: 21125406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pathological studies of IgA nephropathy presenting as a rapidly progressive form of glomerulonephritis.
    Shimizu A; Takei T; Moriyama T; Itabashi M; Uchida K; Nitta K
    Intern Med; 2013; 52(22):2489-94. PubMed ID: 24240786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of the proliferation marker Ki-67 in renal biopsies: correlation to clinical findings.
    Nabokov A; Waldherr R; Ritz E
    Am J Kidney Dis; 1997 Jul; 30(1):87-97. PubMed ID: 9214406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-three-year review of disease patterns from renal biopsies: an experience from a pediatric renal center.
    Yin XL; Zou MS; Zhang Y; Wang J; Liu TL; Tang JH; Qiu LR; Chen Y; Yuan HQ; Zhou JH
    J Nephrol; 2013; 26(4):699-707. PubMed ID: 23661591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.
    Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G
    Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human neutrophil peptide 1-3, a component of the neutrophil extracellular trap, as a potential biomarker of lupus nephritis.
    Cheng FJ; Zhou XJ; Zhao YF; Zhao MH; Zhang H
    Int J Rheum Dis; 2015 Jun; 18(5):533-40. PubMed ID: 25196784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific expression of renin-angiotensin system components in IgA nephropathy.
    Miyake-Ogawa C; Miyazaki M; Abe K; Harada T; Ozono Y; Sakai H; Koji T; Kohno S
    Am J Nephrol; 2005; 25(1):1-12. PubMed ID: 15644622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative study of mesangial deposits and glomerular monocytes/macrophages in IgA-nephropathy and proliferative mesangial (non-IgA) glomerulonephritis.
    Danilewicz M; Wagrowska-Danilewicz M
    J Nephrol; 1998; 11(5):255-60. PubMed ID: 9831239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathological analysis of IgA nephropathy with crescentic formation in childhood].
    Yao Y; Liu JC; Xiao HJ; Huang JP; Yang JY
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):412-6. PubMed ID: 15265422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.